Previous 10 | Next 10 |
home / stock / myco:cc / myco:cc news
Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) is a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders. A recent article discusses the company’s efforts to lead the charge toward developing novel psychedelic an...
Mydecine was founded in 2020 as a response to the lack of innovation addressing mental health treatment and the therapeutic possibilities represented by psychedelic compounds and other novel molecules The world is experiencing a shortage of mental health resources, while faced with an i...
New research has found that the experiences of people who talked about and reported nonsuicidal self-injury on Reddit are similar to individuals who have been diagnosed with substance use disorder. Individuals who posted on a self-injury forum titled r/self-harm in 2010–2019 cited...
A new study has looked into how therapeutic psychedelic administration combined with the calm properties of nature-based settings has the capacity to improve an individual’s mental well-being as well as bolster their relationship with nature. The study was conducted by a team of res...
MYCO-001 Smoking Cessation Clinical Trial Moves Forward Following Conditional IRB Approval Company Advances IP Portfolio With New Patent Applications Covering Novel Molecule Families DENVER, March 31, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MY...
Mydecine Innovations Group Announces Closing of First Tranche Under Share Subscription Agreement Canada NewsWire DENVER , March 31, 2022 /CNW/ - Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) is...
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – March 30, 2022 – Depression and anxiety affect millions around the world and the venom of a toad is the latest psychedelic compound being used as an alternative treat...
Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) , a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders, has continually taken steps toward fulfilling its mission to become a trusted source of safe and effective medication-ba...
Research has found that a virtual connection to a psychiatrist may help people living in rural communities and grappling with bipolar disorder and post-traumatic stress disorder acquire effective care. The randomized study, which was carried out before the coronavirus pandemic, exami...
Prior studies have found that psychedelic substances can alter states of consciousness . However, until now it was unknown which receptors played a role in this change. New research conducted by a group of scientists from various institutions has demonstrated how a drug-induced change in an...
News, Short Squeeze, Breakout and More Instantly...
MYDECINE INNOVATIONS GROUP INC. Company Name:
MYCO:CC Stock Symbol:
AQNC Market:
MYDECINE INNOVATIONS GROUP INC. Website:
A look at the top 10 most actives in Canada Canadian Natural Resources Limited (CNQ) rose 1.6% to $49.86 on volume of 16,918,783 shares Cenovus Energy Inc. (CVE) rose 1.2% to $27.09 on volume of 11,032,869 shares Toronto-Dominion Bank (The) (TD) rose 1.0% to $76.74 on volume of 10,871,605...
A look at the top 10 most actives in Canada Toronto-Dominion Bank (The) (TD) rose 0.3% to $76.13 on volume of 16,847,005 shares Canadian Natural Resources Limited (CNQ) fell 1.5% to $48.33 on volume of 7,922,140 shares TC Energy Corporation (TRP) rose 0.1% to $51.11 on volume of 7,293,869...
(TheNewswire) Vancouver, British Columbia, July 5, 2024— TheNewswire – Mydecine Innovations Group Inc. (the “ Company ”) (CSE: MYCO) (FSE: 0NF0) (OTC: MYCOF) (AQSE: MYIG) is pleased to confirm that further to its news release dated June 13, 2024, ...